Oral Fosfomycin for Pyelonephritis: Time for Evidence Over Eminence-based Guidelines.
Oct 14, 2026DOI: 10.1093/cid/ciag552Journal ArticleCID
Written by: Brad SpellbergSathyavani SubbaraoAlejandro Díaz DíazJean ReginaAlejandro DelgadoScott A CohenMiguel Morante-RuizBoris JegorovićIsabelle ChiuJavier Santiago AraujoErnesto CruzHenco NelEzequiel CordovaBernardo Vidal PimentelSteven Y C TongDaniel T AndersonZachary NelsonNiccolò RiccardiMariana B Caiado FerreiraKusha DavarSarah FrelingDevin ClarkNoah Wald-DicklerRachel BadenNitin GuptaTomas Panesso GomezJacob JarboeIhab AhmedBryan P WhiteJulian VentresKyle SmileyAndrew F ShorrBlain G ThayerJhongert Alza-ArcilaAlberto Enrico MaraoloZeynep ErgencTodd C LeeBander A AssiriJessica S MooreAlasdair P S MunroDanilo BuonsensoGloria M Aguirre-GarciaAndrés Blanco-Di MatteoMatthew C PhillipsJoão Paulo CaldasPascal Meyer-SautterGenevieve McKewBassam Ghanem